Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)
Egypt · Delayed Price · Currency is EGP 250.25
-2.75 (-1.09%)
At close: Feb 22, 2026
EGX:CPCI Revenue
Kahira Pharmaceuticals & Chemical Industries Company had revenue of 601.90M EGP in the quarter ending December 31, 2025, a decrease of -4.71%. This brings the company's revenue in the last twelve months to 2.28B, up 33.69% year-over-year. In the fiscal year ending June 30, 2025, Kahira Pharmaceuticals & Chemical Industries Company had annual revenue of 2.08B with 52.80% growth.
Revenue (ttm)
2.28B
Revenue Growth
+33.69%
P/S Ratio
1.66
Revenue / Employee
1.31M
Employees
1,735
Market Cap
3.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.08B | 718.48M | 52.80% |
| Jun 30, 2024 | 1.36B | 355.61M | 35.38% |
| Jun 30, 2023 | 1.01B | -106.87M | -9.61% |
| Jun 30, 2022 | 1.11B | 50.07M | 4.71% |
| Jun 30, 2021 | 1.06B | 51.61M | 5.11% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition